Skip to main content
. 2015 Oct 8;2015:135298. doi: 10.1155/2015/135298

Figure 4.

Figure 4

(a) Expression of podoplanin in OSCC: weak reactivity (>10% tumor cells positive and weak staining). (b) Expression of podoplanin in OSCC: moderate reactivity (10–30% tumor cells positive and moderate staining). (c) Expression of podoplanin in OSCC: high reactivity (50–80% tumor cells positive and strong staining).